Sepracor, HMR autoimmune/inflammation news

The U.S. Patent and Trademark Office (PTO) declared an interference between patents held by SEPR and HMR covering non-sedating antihistamines.

Read the full 204 word article

How to gain access

Continue reading with a
two-week free trial.